67 institutional investment managers reported RANI positions in their Form 13F filings for Q2 2026, holding 45,546,992 shares worth $34.6M in total. Samsara Biocapital, LLC reported the largest position.

Are funds buying or selling RANI?

In Q2 2026, 11 managers opened new RANI positions, 14 added, 14 trimmed and 15 sold out. Managers that filed in both quarters added a net 6,610,027 shares.

How current is this RANI institutional ownership data?

It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Funds · RANI

Who owns RANI?

Institutional ownership of Rani Therapeutics Holdings Inc. from Form 13F, Q2 2026

67 institutional managers reported holding Rani Therapeutics Holdings Inc. (RANI) in Form 13F filings for Q2 2026, with 45,546,992 shares worth $34.6M. The largest reported holder was Samsara Biocapital, LLC. Managers that filed both quarters added a net 6,610,027 shares (+17.0%). 11 opened new positions and 15 sold out.

Funds holding: 67
Value held: $34.6M
New / sold out: 11 / 15
Net shares, same filers: +17.0%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of RANI

Fund	Value	Share of 13F holdings	Shares	Move
Samsara Biocapital, LLC	$7.9M	22.8%	10,369,159	Added
Ra Capital Management, L.p.	$6.5M	18.7%	8,500,000	Unchanged
AWM Investment Company, Inc.	$5.7M	16.5%	7,500,000	Added
Vanguard Capital Management LLC	$3.5M	10.0%	4,562,985	Trimmed
Longaeva Partners L.P.	$1.8M	5.1%	2,329,459	Unchanged
Polar Asset Management Partners Inc.	$1.8M	5.1%	2,318,542	New
Siren, L.L.C.	$1.5M	4.4%	2,000,000	Unchanged
Heights Capital Management, Inc	$711K	2.1%	934,580	New
Geode Capital Management, LLC	$678K	2.0%	890,618	Trimmed
Citadel Advisors LLC	$488K	1.4%	641,995	New
Marshall Wace, LLP	$446K	1.3%	586,265	New
Nan Fung Group Holdings Ltd	$375K	1.1%	493,584	Unchanged
Jane Street Group, LLC	$369K	1.1%	485,899	Added
Vanguard Fiduciary Trust Co	$348K	1.0%	458,126	Added
Renaissance Technologies LLC	$328K	0.9%	430,737	New
State Street Corp	$284K	0.8%	373,142	Unchanged
BlackRock, Inc.	$260K	0.8%	342,113	Trimmed
United Services Automobile Association	$230K	0.7%	302,743	Unchanged
UBS Group AG	$226K	0.7%	297,270	Added
Kestra Private Wealth Services, LLC	$215K	0.6%	282,340	Added
Gsa Capital Partners LLP	$190K	0.5%	249,716	Added
Northern Trust Corp	$130K	0.4%	170,471	Unchanged
CWA Asset Management Group, LLC	$114K	0.3%	150,000	Unchanged
Bridgeway Capital Management, LLC	$87K	0.3%	114,500	Unchanged
King Luther Capital Management Corp	$44K	0.1%	58,000	Unchanged

Share of 13F holdings is each fund's shares as a share of the 45,546,992 RANI shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

Polar Asset Management Partners Inc. New+$1.8M
Samsara Biocapital, LLC Added+$1.4M
AWM Investment Company, Inc. Added+$760K
Heights Capital Management, Inc New+$711K
Citadel Advisors LLC New+$488K
Marshall Wace, LLP New+$446K
Renaissance Technologies LLC New+$328K
Jane Street Group, LLC Added+$244K
Gsa Capital Partners LLP Added+$116K
UBS Group AG Added+$53K

Biggest sellers in Q2 2026

683 Capital Management, LLC Sold out-$358K
Millennium Management LLC Sold out-$298K
BlackRock, Inc. Trimmed-$163K
Hudson Bay Capital Management LP Sold out-$113K
Susquehanna International Group, LLP Trimmed-$99K
OMERS ADMINISTRATION Corp Sold out-$56K
Vanguard Capital Management LLC Trimmed-$45K
Farallon Capital Management, L.l.c. Trimmed-$44K
Qube Research & Technologies Ltd Sold out-$35K
NINE MASTS CAPITAL Ltd Sold out-$33K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $6.4M and sold $1.4M; 14 added and 14 trimmed.

Schedule 13D and 13G filings on RANI

Owners of more than 5% must file within days, so these can be newer than the 13F data.

2026-02-13AWM Investment Company, Inc. SCHEDULE 13G filed by Rani Therapeutics Holdings Inc.Schedule 13G
2026-01-30VANGUARD GROUP INC SCHEDULE 13G filed by Rani Therapeutics Holdings Inc.Schedule 13G
2025-10-30Samsara BioCapital, L.P. SCHEDULE 13D filed by Rani Therapeutics Holdings Inc.Schedule 13D
2025-10-30RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by Rani Therapeutics Holdings Inc.Schedule 13G
2025-08-15ARMISTICE CAPITAL, LLC SCHEDULE 13G filed by Rani Therapeutics Holdings Inc.Schedule 13G

Questions about RANI ownership

Who owns RANI stock?: 67 institutional investment managers reported RANI positions in their Form 13F filings for Q2 2026, holding 45,546,992 shares worth $34.6M in total. Samsara Biocapital, LLC reported the largest position.
Are funds buying or selling RANI?: In Q2 2026, 11 managers opened new RANI positions, 14 added, 14 trimmed and 15 sold out. Managers that filed in both quarters added a net 6,610,027 shares.
How current is this RANI institutional ownership data?: It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to RANI by CUSIP. Options are left out. RANI news and filings · RANI insider trades · Top funds